554 related articles for article (PubMed ID: 19604653)
1. Differences in clinical results after LINAC-based single-dose radiosurgery versus fractionated stereotactic radiotherapy for patients with vestibular schwannomas.
Combs SE; Welzel T; Schulz-Ertner D; Huber PE; Debus J
Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):193-200. PubMed ID: 19604653
[TBL] [Abstract][Full Text] [Related]
2. Hearing preservation after radiotherapy for vestibular schwannomas is comparable to hearing deterioration in healthy adults and is accompanied by local tumor control and a highly preserved quality of life (QOL) as patients' self-reported outcome.
Combs SE; Welzel T; Kessel K; Habermehl D; Rieken S; Schramm O; Debus J
Radiother Oncol; 2013 Feb; 106(2):175-80. PubMed ID: 23333012
[TBL] [Abstract][Full Text] [Related]
3. Single fraction versus fractionated linac-based stereotactic radiotherapy for vestibular schwannoma: a single-institution experience.
Collen C; Ampe B; Gevaert T; Moens M; Linthout N; De Ridder M; Verellen D; D'Haens J; Storme G
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e503-9. PubMed ID: 21665381
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic radiosurgery vs. fractionated radiotherapy for tumor control in vestibular schwannoma patients: a systematic review.
Persson O; Bartek J; Shalom NB; Wangerid T; Jakola AS; Förander P
Acta Neurochir (Wien); 2017 Jun; 159(6):1013-1021. PubMed ID: 28409393
[TBL] [Abstract][Full Text] [Related]
5. Radiotherapy in patients with vestibular schwannoma and neurofibromatosis type 2: clinical results and review of the literature.
Wagner J; Welzel T; Habermehl D; Debus J; Combs SE
Tumori; 2014; 100(2):189-94. PubMed ID: 24852864
[TBL] [Abstract][Full Text] [Related]
6. Progression of hearing loss after LINAC-based stereotactic radiotherapy for vestibular schwannoma is associated with cochlear dose, not with pre-treatment hearing level.
van Linge A; van Os R; Hoekstra N; Heijmen B; Stienstra L; Dallenga A; Wolbers J; Mendez Romero A
Radiat Oncol; 2018 Dec; 13(1):253. PubMed ID: 30583739
[TBL] [Abstract][Full Text] [Related]
7. LINAC-based stereotactic radiosurgery versus hypofractionated stereotactic radiotherapy delivered in 3 or 5 fractions for vestibular schwannomas: comparative assessment from a single institution.
Söderlund Diaz L; Hallqvist A
J Neurooncol; 2020 Apr; 147(2):351-359. PubMed ID: 32036575
[TBL] [Abstract][Full Text] [Related]
8. Management of acoustic neuromas with fractionated stereotactic radiotherapy (FSRT): long-term results in 106 patients treated in a single institution.
Combs SE; Volk S; Schulz-Ertner D; Huber PE; Thilmann C; Debus J
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):75-81. PubMed ID: 16111574
[TBL] [Abstract][Full Text] [Related]
9. Gamma knife radiosurgery in younger patients with vestibular schwannomas.
Lobato-Polo J; Kondziolka D; Zorro O; Kano H; Flickinger JC; Lunsford LD
Neurosurgery; 2009 Aug; 65(2):294-300; discussion 300-1. PubMed ID: 19625908
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic fractionated radiotherapy and LINAC radiosurgery in the treatment of vestibular schwannoma-report about both stereotactic methods from a single institution.
Kopp C; Fauser C; Müller A; Astner ST; Jacob V; Lumenta C; Meyer B; Tonn JC; Molls M; Grosu AL
Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1485-91. PubMed ID: 20708852
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcome after highly advanced single-dose or fractionated radiotherapy in patients with vestibular schwannomas - pooled results from 3 large German centers.
Combs SE; Engelhard C; Kopp C; Wiedenmann N; Schramm O; Prokic V; Debus J; Molls M; Grosu AL
Radiother Oncol; 2015 Mar; 114(3):378-83. PubMed ID: 25702864
[TBL] [Abstract][Full Text] [Related]
12. Single institution experience treating 104 vestibular schwannomas with fractionated stereotactic radiation therapy or stereotactic radiosurgery.
Anderson BM; Khuntia D; Bentzen SM; Geye HM; Hayes LL; Kuo JS; Baskaya MK; Badie B; Basavatia A; Pyle GM; Tomé WA; Mehta MP
J Neurooncol; 2014 Jan; 116(1):187-93. PubMed ID: 24142200
[TBL] [Abstract][Full Text] [Related]
13. Increased cochlear radiation dose predicts delayed hearing loss following both stereotactic radiosurgery and fractionated stereotactic radiotherapy for vestibular schwannoma.
Patel KS; Ng E; Kaur T; Miao T; Kaprealian T; Lee P; Pouratian N; Selch MT; De Salles AAF; Gopen Q; Tenn S; Yang I
J Neurooncol; 2019 Nov; 145(2):329-337. PubMed ID: 31552587
[TBL] [Abstract][Full Text] [Related]
14. Fractionated stereotactic radiotherapy of vestibular schwannomas accelerates hearing loss.
Rasmussen R; Claesson M; Stangerup SE; Roed H; Christensen IJ; Cayé-Thomasen P; Juhler M
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e607-11. PubMed ID: 22560549
[TBL] [Abstract][Full Text] [Related]
15. Image-guided stereotactic radiotherapy for patients with vestibular schwannoma. A clinical study.
Badakhshi H; Muellner S; Wiener E; Budach V
Strahlenther Onkol; 2014 Jun; 190(6):533-7. PubMed ID: 24589920
[TBL] [Abstract][Full Text] [Related]
16. Hearing Preservation for Vestibular Schwannomas Treated with Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy.
Udawatta M; Kwan I; Preet K; Nguyen T; Ong V; Sheppard JP; Duong C; Romiyo P; Lee P; Tenn S; Kaprealian T; Gopen Q; Yang I
World Neurosurg; 2019 Sep; 129():e303-e310. PubMed ID: 31132496
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcome of stereotactic radiosurgery (SRS) in patients with acoustic neuromas.
Combs SE; Thilmann C; Debus J; Schulz-Ertner D
Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1341-7. PubMed ID: 16464537
[TBL] [Abstract][Full Text] [Related]
18. Single-dose versus fractionated stereotactic radiotherapy for brain metastases.
Kim YJ; Cho KH; Kim JY; Lim YK; Min HS; Lee SH; Kim HJ; Gwak HS; Yoo H; Lee SH
Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):483-9. PubMed ID: 20800386
[TBL] [Abstract][Full Text] [Related]
19. Stereotactic radiosurgery for vestibular schwannomas: average 10-year follow-up results focusing on long-term hearing preservation.
Watanabe S; Yamamoto M; Kawabe T; Koiso T; Yamamoto T; Matsumura A; Kasuya H
J Neurosurg; 2016 Dec; 125(Suppl 1):64-72. PubMed ID: 27903183
[TBL] [Abstract][Full Text] [Related]
20. Hearing Outcomes After Stereotactic Radiosurgery for Vestibular Schwannomas : Mechanism of Hearing Loss and How to Preserve Hearing.
Han JH; Kim DG; Chung HT; Paek SH; Jung HW
Adv Tech Stand Neurosurg; 2016; (43):3-36. PubMed ID: 26508404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
